A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression

While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in preclinical models, its role in ER+ BMETs, representing the majority of clinical BMETs, has not been documented. Experiments were un...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Julia N., Frye, Jennifer B., Whitman, Susan A., Kunihiro, Andrew G., Pandey, Ritu, Funk, Janet L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123146/
https://www.ncbi.nlm.nih.gov/pubmed/33923316
http://dx.doi.org/10.3390/ijms22094463